This study wouldn't have been possible without the team effort of the @AppelGroup on these pharmacokinetic studies! And special shoutout to @AntonAASmith for his contributions on our initial monomeric insulin - the basis for this ultrafast formulation!
An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients https://t.co/LPS50uLk84
RT @DanielJDrucker: Can improved ultrafast insulin formulations improve glucose control for PPL w #diabetes #T1D @ScienceTM https://t.co/px…
RT @AppelGroup: Check out our new work on development of an ultrafast insulin formulation enabled by high-throughput screening of engineere…
My co-lead author @JosephLMann and I are excited to share this new paper from the @AppelGroup where we showcase our new "AC/DC" excipients to enable a stable ultrafast insulin formulation! https://t.co/hYmz7RJUeB
Eric’s on 🔥!!
RT @DanielJDrucker: Can improved ultrafast insulin formulations improve glucose control for PPL w #diabetes #T1D @ScienceTM https://t.co/px…
Check out our new work on development of an ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients by @CMaikawa and @JosephLMann in @ScienceTM @StanfordMSE @StanfordBioE @StanfordEng https://t.co/2BtpS7Oo74
RT @DanielJDrucker: Can improved ultrafast insulin formulations improve glucose control for PPL w #diabetes #T1D @ScienceTM https://t.co/px…
RT @DanielJDrucker: Can improved ultrafast insulin formulations improve glucose control for PPL w #diabetes #T1D @ScienceTM https://t.co/px…
Can improved ultrafast insulin formulations improve glucose control for PPL w #diabetes #T1D @ScienceTM https://t.co/pxLE6T34Sn